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ABSTRACT
Acute diarrheal disease is still one of the major public health problems worldwide. Rotaviruses (RV) 
are the most important viral etiologic agents and children under fi ve years of age are the target 
population. Objective: To investigate the rate of RV infection in hospitalized patients due to acute 
diarrhea in the cities of Ponta Grossa, Londrina and Assai - Paraná. Methods: Latex agglutination 
(LA); immunochromatography (ICG); polyacrylamide gel electrophoresis (PAGE) and negative 
staining electron microscopy (ME) tests were used to detect the virus. For the genotyping, RT-PCR 
and RT-PCR-ELISA were used, respectively, for NSP4 and VP4/VP7. Result: Out of 124 samples 
there were 69 positive stool samples for RV, for at least one of the used tests, 67 of them being RV 
group A (RV-A). Overall, most of the RV positive stool samples came from children under thirteen 
years of age. However, 12 positive cases occurred in patients aged 13 years or above, including an 
81-year old patient. Conclusion: The data showed similar electropherotypes and genotypes G, P and 
NSP4 of the inland wild circulating strains of RV.
Keywords: rotavirus; determination; hospitalized patients; genotyping.
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INTRODUCTION
Acute diarrheal disease is still one of the major 
public health problems worldwide. Rotaviruses 
(RV) are the most important etiologic agents and 
children under fi ve years of age are the preferred 
target population. Moreover, a variety of infant 
animals are equally affected by species-specifi c vi-
rus strains. Worldwide, RV cause approximately 
112 millions of domestic episodes of diarrhea, 25 
millions of clinic visits, 2 millions of hospitaliza-
tions and about 611,000 deaths of children under 
fi ve years of age, annually.1
RV are icosahedric virions, non-enveloped, 
and present a triple concentric layers of proteins.2,3 
The inner layer is formed by virus protein 2 
(VP2) that involves the genome, the VP1 (RNA 
polymerase dependent of RNA) e a VP3 (guani-
lyltransferase and methylase). The intermediate 
layer is made up of VP6 associated with VP2 and 
confers the structure the so-called double-layered 
particles (DLP). The outer layer is constituted by 
trimeric structures of VP7 glycoprotein and the 
dimeric spikes of VP4 forming the triple-layered 
particles (TLP), the infectious form of the virus. 
Virus genome is represented by 11 segments of 
double-stranded RNA that encode, respectively, 
six structural proteins (VP1-VP4, VP6 and VP7) 
and six nonstructural proteins (NSP1-NSP6). 
Based on antigenic specifi city of VP6, RV are 
classifi ed into seven groups (A-G), prevailing the 
infections by group A strains (RV-A).2 Moreover, 
VP6 epitopes allow the differentiation of group A 
strains into sub-groups (SG-I, SG-II, SG-I/II, and 
non-SG-I/II), prevailing SG-II in human infec-
tions.4 These strains are molecularly distinguished 
into genogroup I (SG-I) and genogroup II (SG-II, 
SG-I/II, and SG non-I,non II).5 G and P genotyp-
ing is attributed, respectively, to VP7 and VP4.2 
Twenty-three G and 31 P genotypes have been 
described.6,7 Due to the importance of NSP4 pro-
tein in the virion morphogenesis, replication and 
in the pathogeny of the infection this protein was 
also defi ned molecularly into six genotypes (A-F).4
Genotypes G1-G4 and G9 combined with 
P[8] and P[4] are the most prevalent worldwide 
(approximately 90%).9,10 Concerning NSP4 gen-
otyping, B type has been shown to be the most 
common in the world.11,12 
A more complex though complete classifi cation 
of group A RV has been proposed based on the mo-
lecular analysis of all eleven genome segments.8 
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By poliacrylamide gel electrophoresis (PAGE) RV are classi-
fi ed into seven electropherotypes (e-type) from A-G, according 
to the migration pattern of the 11 RNA segments. Moreover, 
group A strains can be further classifi ed according to the mo-
bility of the segments 10 and 11 into long (L), short (S) and 
super-short (SS) electropherotypes according to the migration 
pattern.13,14
Presently, two types of RV vaccine are commercially avail-
able for human use (Rotarix and RotaTeq) and their safety and 
effi cacy to prevent and/or attenuate severe diarrheal episodes 
have been proved.15,16
Bearing in mind the genetic variability of the virus, either 
vaccine or host natural immunity to the virus or both may pose 
a selective pressure that may result in emergence of unusual 
genotypes. Crossing species barrier is also another possibility for 
the appearance of mutant strains. In fact, hitherto undescribed 
genotypes have been found.17 These selective events may repre-
sent a signifi cant antigenic “shift” or “drift”, as has been shown 
for inﬂ uenza virus with a real impact in the epidemiology of 
the disease. Therefore, it is important to monitor wild strains 
of the virus in order to evaluate all these consequences, and to 
accompany the evolution of the infection.
In this paper we evaluated circulating human RV strains 
in three locations of the State of Paraná, Brazil.
MATERIAL AND METHODS
Feces
One hundred and twenty four fecal samples were collected 
from April 2005 to March 2009 from hospitalized patients 
suffering from acute diarrhea, admitted to private and pub-
lic hospitals in the cities of Assai (Hospital Climas), Lond-
rina (Hospital Universitário Regional do Norte do Paraná) 
and Ponta Grossa (Hospital Bom Jesus) - Paraná. The study 
protocol was approved by the Experimental Ethics Commit-
tee of the Universidade Estadual de Londrina, under the nº 
01840268000-07.
Negative staining electron microscopy
For transmission electron microscopy (EM) raw stool sam-
ples were processed by super direct negative staining with 2% 
sodium phosphotungstate, pH 6.3, as described elsewhere.18
Immunochromatography and latex agglutination tests
Stool samples were also homogenized at 20% (vol/vol) in 
PBS, pH 7.3, and clarifi ed by centrifugation at 450xg/10 min. 
Clarifi ed homogenate were submitted to Vikia - Rota Adeno, 
Biomérieux SA, Fr. and/or Virotect Rota, Omega Diagnostic 
Ltd., UK., according to the manufacturers recommendations.
Polyacrilamide gel electrophoresis
Clarifi ed fecal homogenates were further submitted to virus 
RNA extraction, as described before,19 for PAGE.
RT-PCR and PCR-ELISA
For RT-PCR virus RNA was extracted from stools using the 
TRIzol method (Invitrogen, Carlsbad, USA) and subjected to 
reverse transcription followed by PCR.20 The cDNA of VP7 
or VP4 gene was synthesized by using primers labeled with 
biotin at their 5’ ends. For PCR-ELISA detection of labeled 
PCR products and identifi cation of the genotypes of posi-
tive samples, brieﬂ y, 96-well microplates (Nunc-Immuno 
module, Nunc, Roskilde, Denmark) coated with streptavi-
din (Roche Diagnostic GmbH, Mannheim, Germany) were 
used. To each well the biotin-labeled PCR product was dis-
tributed (one reaction per genotype) followed by the addi-
tion of type-specifi c digoxigenin-labeled probe. Individual 
G- or P-type specifi c probe mixtures (three type-specifi c 
probes/genotype/mixture) were distributed onto the plates. 
This was followed by the addition of anti-digoxigenin per-
oxidase conjugate (Roche Diagnostic GmbH); the substrate 
(TMB peroxidase substrate system; KPL, Gaithersburg, 
MD), and absorbance read at 450 nm within 10 min.21 For 
NSP4 typing, nested-PCR was used and primers are listed in 
Table 1, including those for VP7 and VP4 typing.
Rotavirus in hospitalized patients
Table 1. VP7, VP4 and NSP4 primers used for amplification and genotyping
Primers Sequences Positions Genes
Beg9 (+) GGCTTTAAAAGAGAGAATTTCCGTCTGG 1036–1062 VP7
End9 (–) GGTCACATCATACAATTCTAATCTAAG 1–28 VP7
Con2 (–) ATTTCGGACCATTTATAACC 887–868 VP4
Con3 (+) TGGCTTCGCTCATTTATAGACA 11–32 VP4
NSP4-1a (+) GGCTTTTAAAAGTTCTGTTCCG 1–12 NSP4
NSP4-2b (–) GGTCACATTAAGACCGTTCC 750–731 NSP4
NSP4-Kun-1a (+) ATTGATAGTGCGATCGACTGG 439–460 NSP4-A
NSP4-Wa-1a (+) GGCTGGATATAAAGAGCAGG 286–306 NSP4-B
NSP4-RRV-1a (+) AACGATTGGGCTGAAAGGTG 508–528 NSP4-C  
555Braz J Infect Dis 2010; 14(6):553-557
RESULTS
From 124 stool samples evaluated 69 were positive for RV 
(55.6%), for at least one of the methods used. Amongst these 69 
positive samples, 63 (88.4%) were considered group A (RV-A), 
as demonstrated by serological methods, being positive either by 
ICG or LA. Additionally, four strains were also defi ned as RV-A 
by electrophoretic pattern by PAGE. Therefore, overwhelmingly, 
a total of 67 strains out of 69 (97.1%) were RV-A. Individually, 
the performance of the methods used accounted for the follow-
ing results (Table 2): For LA, 66 samples were analyzed and 
23 were positive (34.8%). For ICG, 40 samples were positive 
out of 64 (62.5%). For PAGE, out of 124 samples 47 were 
positive (37.9%), being 26 strains, 55.2% (26/47), with short pat-
tern electropherotypes and 20, 42.5% (20/47), with long 
pattern. For EM, 47 samples were tested and 11 were positive 
(23.4%). As far as genotyping is concerned, out of the 124 
samples, 44 samples (35.4%) were amplifi ed as following. 
Nozawa, Kerntopf, Czernisz et al.
PGR05/032 7 + ND L ND NTD NTD NTD
PGR05/033 4 + ND L ND G1 P[8] B
PGR05/034 1 + ND - ND G1 NTD B
PGR05/039 2 + ND L + G1 P[8] B
PGR05/042 58 + ND L + G9 P[8] B
PGR05/043 46 + ND L ND NTD P[8] B
PGR05/045 22 + ND NTD ND NTD NTD B
PGR05/046 8* + ND L ND G9 P[8] B
PGR05/049 3 + ND L + G1 P[8] NTD
PGR08/001 4 ND + S ND NTD P[4] A
PGR08/002 81 ND + S ND G2 P[4] A
PGR08/003 5 ND + - - NA NA NA
PGR08/004 4 ND + S ND G2 P[4] A
PGR08/005 2 ND + - - NA NA NA
PGR08/006 1 ND + S ND NTD P[4] A
PGR08/007 3 ND + S ND NTD P[4] A
PGR08/008 3 ND + - - NA NA NA
PGR08/009 10 ND + - - NA NA NA
PGR08/010 6 ND + - - NA NA NA
PGR08/011 1 ND + S ND G2 P[4] A
PGR08/012 6 ND + - - NA NA NA
PGR08/013 22 ND + S ND G2 P[4] A
PGR08/014 2 ND + - - NA NA NA
PGR08/015 2 ND + S ND NTD NTD A
PGR08/016 1 ND + S ND NTD P[4] A
PGR08/017 52 ND + S ND NTD NTD A
PGR08/018 21 ND + S + G2 P[4] A
PGR08/019 3 ND + - - NA NA NA
PGR08/020 3 ND + - - NA NA NA
PGR08/021 4 ND + S ND NTD P[4] A
PGR08/022 5 ND + S ND G2 P[4] A
PGR08/023 4 ND + S ND NTD P[4] A
PGR08/024 3 ND + S ND G2 P[4] A
PGR08/025 30 ND + S ND G2 P[4] A
PGR08/026 7 ND + - - NA NA NA
PGR08/027 63 ND + S + NTD NTD A
PGR08/028 6 ND + - - NA NA NA
PGR08/029 45 ND + S ND G2 NTD A
PGR08/030 1 ND + S ND G2 P[4] A
PGR08/031 4 ND + - - NA NA NA
PGR08/032 4 ND + S ND G2 P[4] A
PGR08/033 1 ND + S + NTD NTD A
PGR08/034 1 ND + - ND NA NA NA
aEletropherotype: L - long, S - short.
bAntigenic specificity carried by indicated proteins.
cND, not done.
dNA, not amplified.
eNTD, not determined.
+ positive/- negative.
Table 2. Rotavirus strains with the respective 
methods of detection/typing
Strain Age LA ICG E-typea EM      Genotypesb
 (yrs./
 mos.*)
      VP7 VP4 NSP4
ASS08/001 1 NDc - - + NAd NA NA
ASS08/003 4 ND + L + NTDe NTD A
ASS08/004 2 ND - - + NA NA NA
LON08/016 2 + ND S ND G2 P[4] A
LON08/018 2 + ND S ND G2 P[4] A
LON08/019 3 - ND S ND NTD NTD A
LON08/022 7 + ND S + NTD NTD NTD
PGR05/001 1 - ND - - NTD NTD B
PGR05/002 3 + ND L ND G1 NTD B
PGR05/006 3 + ND - - NTD NTD NTD
PGR05/010 11 - ND L + G1 P[8] B
PGR05/011 6 + ND L ND NTD P[8] B
PGR05/012 1 + ND L ND NTD NTD NTD
PGR05/013 10 + ND - - NA NA NA
PGR05/015 1 + ND L ND G1 P[8] B
PGR05/016 12 + ND L ND G1 P[8] B
PGR05/019 14 - ND - - NTD NTD B
PGR05/020 2 + ND L ND NTD NTD B
PGR05/021 9 + ND - - NA NA NA
PGR05/023 4* + ND L ND NTD NTD NTD
PGR05/024 8* - ND L ND NTD NTD B
PGR05/025 1 + ND - ND NTD NTD NTD
PGR05/026 14 + ND S ND NTD P[8] B
PGR05/027 9* + ND L ND G1 P[8] B
PGR05/030 1 - ND L ND NTD NTD NTD
PGR05/031 7 + ND L ND NTD NTD NTD
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Eleven samples amplifi ed, individually, either for NSP4-A 
(6) or NSP4-B (5). Thirteen samples amplifi ed for the dou-
ble combinations G1/NSP4-B (2), G1P[8] (1), G2/NSP4-A 
(1), P[4]/NSP4-A (6), and P[8]/NSP4-B (3). Twenty samples 
amplifi ed for the triple combinations G1P[8]/NSP4-B (6), 
G2P[4]/NSP4-A (12) and G9P[8]/NSP4-B (2). Genotypes 
G1, G2 and G9 accounted for 37.5% (9/24), 54.1% (13/24), 
and 8.3% (2/24) of the strains detected, respectively. In our 
study genotyping VP4 demonstrated that P[4] was prevalent 
in 56.2% (18/32) in comparison to 43.7% (14/32) of P[8]. 
Genotyping of NSP4 accounted for 56.8% (25/44) for type 
A and 43.2% for type B.
According to the ages of the patients, out of 124 stool 
samples 57 came from children and young children 
(≤ twelve years of age) (82.6%, 57/69). Positive cases in 
adults were detected in twelve patients over 12 years, includ-
ing an 81-year-old male patient, overall representing 17.4% 
(12/69) (Table 3).
DISCUSSION AND CONCLUSION
This study demonstrated the outstanding importance of 
RV as the causative of acute diarrheal disease, account-
ing for a positivity of 55.6%, particularly because all the 
subjects studied were hospitalized patients. Overwhelm-
ingly, most of the RV positive stool samples were from 
children under six years of age. This epidemiological 
feature has been taken for granted, but, increasingly, 
adults have been affected by the disease. Infection of RV 
in adults seems to be common and has been reported 
mainly among geriatric patients, disabled individuals, 
health attendants and those living in households with 
diseased children.22-25 In the present work, we found that 
17.4% of RV positive samples were detected in adults 
from 12 years of age, including an 81-year old patient. 
It is suggested that the number of adults infected by RV 
would be greater, and studies involving them should be 
encouraged. It has been suggested that symptomatic or 
asymptomatic adults could serve as source of infection 
Rotavirus in hospitalized patients
Table 3. Distribution of rotavirus positive cases 
according to the age of the patients
 Age group (year) n (%) 
   
 ≥ 2 17 (24.6) 
 2-12 40 (58.0) 
 > 12 12 (17.4) 
 Total 69 (100) 
to children.26,27 In this study RV-A, as a rule, account-
ed for 97.1% of the cases, as most of the world reports 
have demonstrated.28-30 The electropherotypes of these 
strains of RV-A showed a slight predominance of short 
pattern in comparison to the long-pattern strains, al-
beit, unusual, this has been reported in India.31 In gen-
eral, the predominance of long e-types has been re-
ported throughout the world,32-36 however, variation 
has been shown according to some genotypes. As far as 
VP7 genotyping is concerned, our study revealed greater 
incidence of G2 secondly by G1. Although in general, 
greater incidence has been attributed to G1 worldwide, 
in Brazil, however, temporally/seasonally there has been 
a change of prevalence between G1 and G2, as demon-
strated elsewhere.29,37 In our study, the greater incidence 
of G2 may be explained by geographical features or due 
to the small sampling. Nevertheless, these results dem-
onstrated the occurrence of G types common in most of 
the countries, including Brazil9,10,37 combined with P[4] 
or P[8]. For VP4 genotyping, similar prevalence profile 
has been found in other countries and in Brazil, and the 
analysis underlying varied epidemiological features is 
also possible, between the two major genotypes presently 
found, P[4] and P[8]. As for NSP4 genotyping, we found 
that type A accounted for the most strains detected. B 
type NSP4 has been shown the most common in the 
world.11,12 However, in Brazil, this is true for the south-
eastern area,38 but not for the northern region, where A 
type is prevalent.39 The data reported in our work dem-
onstrated similar profile of the wild circulating strains 
of RV, as compared to data obtained elsewhere in the 
world and in our country. Molecular and serological nu-
ances are mainly attributed to factors, such as RV geno-
typic and phenotypic variability; interspecies barriers 
crossing; host immunity pressure - naturally or artifi-
cially acquired, as well as, geographical and seasonal fea-
tures. The apparent increase of adult infection and the 
increasing number of untyped strains, albeit, positive by 
other tests, as we found in our work, may be a dem-
onstration of a constant genetic variability. Therefore, 
the emergence of new RV strains should be expected. 
The effect of RV vaccination recently launched in Brazil 
is of major benefit for preventing the disease. However, 
changing in RV genotypes might also be expected as a 
result of a selective evolutionary process. In concluding, 
the threat posed by RV still represents a heavy sanitary 
and economical burden and has to be carefully treated.
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